Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases

A Batata1, B Shen

  • 1Department of Pathology, Cox Institute, Wright State University School of Medicine, Dayton, Ohio 45429.

Cancer
|November 15, 1992
PubMed

Insights

Immunophenotyping using four immune markers accurately differentiates chronic lymphoid leukemia subtypes. This analysis reveals a continuous B-cell differentiation spectrum from early to late mature stages in these leukemias.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • The French-American-British (FAB) classification for chronic lymphoid leukemias (CLL) requires further characterization.
  • Immunophenotyping offers a method to expand and refine the understanding of these hematologic malignancies.

Purpose of the Study:

  • To evaluate the utility of immunophenotyping in differentiating subtypes of chronic lymphoid leukemias.
  • To establish a minimum set of immune markers for accurate diagnosis of CLL subtypes.

Main Methods:

  • Peripheral blood samples from 242 patients with various chronic lymphoid leukemia subtypes were analyzed.
  • Immunologic evaluation included surface immunoglobulin (SIg) intensity, mouse rosettes (MR), CD5, and CD22 expression.

Main Results:

  • Distinct immunophenotypes were identified: CLL and CLL-pleomorphic lymphocytes (CLL-pleo) showed weak SIg, MR+, CD5+, CD22-. Prolymphocytic leukemia (PLL) and hairy cell leukemia (HCL) exhibited strong SIg, MR-, CD5-, CD22+.
  • A combination of these four markers achieved 100% diagnostic accuracy for CLL, CLL-pleo, PLL, and HCL.
  • CLL/PL cases displayed mixed phenotypes, with 66.67% resembling CLL and 33.33% resembling PLL.

Conclusions:

  • Surface immunoglobulin intensity, mouse rosette assay, CD5, and CD22 are essential for the differential diagnosis of chronic lymphoid leukemia subtypes.
  • CLL and CLL-pleo share identical phenotypes, suggesting a close relationship.
  • The immunophenotypic data support a model of continuous B-cell differentiation across CLL subtypes, from early mature (CLL, CLL-pleo) to late mature stages (PLL, HCL).
Abstract

Related Concept Videos